Wick, Wolfgang
Krendyukov, Andriy http://orcid.org/0000-0001-8557-1520
Junge, Klaus
Höger, Thomas
Fricke, Harald
Funding for this research was provided by:
Apogenix AG
Article History
Received: 22 August 2019
Accepted: 19 October 2019
First Online: 2 November 2019
Compliance with ethical standards
:
: Wolfgang Wick reports receiving a commercial research grant from Boehringer Ingelheim and Roche; speaker’s bureau honoraria from Prime Oncology; and is a consultant/advisory board member for Eli Lilly and Co. and Roche. Andriy Krendyukov and Thomas Höger are employees of Apogenix. No potential conflicts of interest were disclosed by Klaus Junge.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study at the time of study conduct.